Manufacturer record
Omega Pharma: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
15 batches manufactured by Omega Pharma (Uttarakhand) were declared Not of Standard Quality between May 2019 and April 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: GT50135, Ciprofloxacin Tablets I.P. 500 mg (exp Apr 2028). DTL Jaipur (state lab) found it not of standard quality: The sample does not conform to the IP with respect to Assay and Dissolution of Ciprofloxacin Hydrochloride Equivalent to Ciprofloxacin. Listed in the April 2026 alert.
Records by type
15 records linked to Omega Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ciprofloxacin Tablets I.P. 500 mg | Batch GT50135Mfg May 2025 · Exp Apr 2028 | The sample does not conform to the IP with respect to Assay and Dissolution of Ciprofloxacin Hydrochloride Equivalent to Ciprofloxacin.Assay | DTL JaipurState lab | Apr 2026 |
| Ciprofloxacin Tablets I.P. 500 mg | Batch GT31156Mfg Mar 2024 · Exp Feb 2026 | The sample does not conform to I.P. with respect to Description.Description | CDL, KolkataCDSCO lab | Mar 2026 |
| Aceclofenac, Paracetamol & Serratiopeptidase Tablets (100mg/325mg/15mg) | Batch GT50230Mfg Jul 2025 · Exp Jun 2027 | The sample does not conform to Manufacturer Method with respect to Assay of Serratiopeptidase.Assay | CDL, KolkataCDSCO lab | Feb 2026 |
| Co-trimoxazole Tablets I.P. (D.S.= Double Strength) | Batch PT30119Mfg May 2023 · Exp Apr 2025 | Dissolution (Sulphamethoxazol e and Trimethoprim)Dissolution | RDTL GuwahatiCDSCO lab | Feb 2025 |
| Co- trimoxazole Tablets I.P. (D.S.=Double Strength) | Batch PT30119Mfg May 2023 · Exp Apr 2025 | Dissolution (Trimethoprim and Sulphamethoxazo le)Dissolution | RDTL GuwahatiCDSCO lab | Dec 2024 |
| Ibuprofen and Paracetamol Tablets I.P. (400 mg/325 mg) | Batch GT1153Mfg Jun 2022 · Exp May 2024 | Dissolution of Ibuprofen and ParacetamolDissolution | RDTL GuwahatiState lab | Oct 2023 |
| Ivermectin Tablets USP | Batch PT0031Mfg May 2021 · Exp Apr 2023 | DissolutionDissolution | RDTL GuwahatiState lab | Aug 2022 |
| Piroxicam Capsules IP 20 mg PIROCAM-20 CAPSULES | Batch PC0014Mfg Apr 2021 · Exp Mar 2023 | WaterWater content | RDTL ChandigarhState lab | Aug 2021 |
| NORFLOXACIN TABLETS IP 400 MG | Batch GPT9412Mfg Dec 2019 · Exp Nov 2021 | DissolutionDissolution | RDTL ChandigarhState lab | Aug 2021 |
| DEXTROMETHORP HAN HYDROBROMIDE SYRUP IP 30MG/5ML | Batch GL0015Mfg Apr 2021 · Exp Mar 2023 | AssayAssay | RDTL ChandigarhState lab | Aug 2021 |
| DEXTROMETHORP HAN HYDROBROMIDE SYRUP IP 30MG/5ML | Batch GL0016Mfg Apr 2021 · Exp Mar 2023 | AssayAssay | RDTL ChandigarhState lab | Aug 2021 |
| Erythromycin Stearate Tablets IP 250 MG | Batch GPT004Mfg Oct 2018 · Exp Sep 2020 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Dec 2019 |
| M-BETASONE (Betamethasone Tablets I.P. 0.5 mg) | Batch OPT7531Mfg Jan 2018 · Exp Jun 2020 | Assay & Related substancesAssay | CDL KolkataCDSCO lab | Jun 2019 |
| Erythromycin Stearate Tablets I.P. 250mg | Batch GPT005Mfg Oct 2018 · Exp Sep 2020 | DissolutionDissolution | CDL KolkataCDSCO lab | May 2019 |
| Erythromycin Stearate Tablets I.P. 250mg | Batch GPT003Mfg Oct 2018 · Exp Sep 2020 | DissolutionDissolution | CDL KolkataCDSCO lab | May 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.